Clinical Associate Professor Rosemary Balleine

Clinical Associate Professor
Medicine, Westmead Clinical School
Westmead Millennium Institute for Medical Research

C24 - Westmead Hospital
The University of Sydney
NSW 2006 Australia

T: 9845 8086
F: 9845 9102

On this page

Themes | Grants | Keywords | Publications


Current national competitive grants*


A Multi-site study of Tamoxifen dose escalation study in breast cancer patients with CYP2D6 polymorphisms (TADE study)
Gurney H, Balleine R, Wilcken N, Liddle C
NHMRC Project Grants ($329,901 over 3 years)

* Grants administered through the University of Sydney


Breast cancer


2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008


  • Pathmanathan, N., Balleine, R., Jayasinghe, U., Bilinski, K., Provan, P., Byth, K., Bilous, A., Salisbury, E., Boyages, J. (2014), The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer. Journal of Clinical Pathology. 67(3), 222-228. [Abstract]
  • Gao, B., Russell, A., Beesley, J., Chen, X., Healey, S., Henderson, M., Wong, M., Emmanuel, C., Galletta, L., Johnatty, S., Bowtell, D., Haber, M., Norris, M., Harnett, P., Chenevix-Trench, G., Balleine, R., Defazio, A. (2014), Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer. Scientific Reports. 4, 4669. [Abstract]


  • Webster, L., Provan, P., Graham, D., Byth, K., Walker, R., Davis, S., Salisbury, E., Morey, A., Ward, R., Hawkins, N., Clarke, C., Meltzer, P., Balleine, R. (2013), Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33. Pathology. 45(7), 629-636. [Abstract]
  • Pathmanathan, N., Balleine, R. (2013), Ki67 and proliferation in breast cancer. Journal of Clinical Pathology. 66(6), 512-516. [Abstract]


  • Pathmanathan, N., Provan, P., Mahajan, H., Hall, G., Byth, K., Bilous, A., Balleine, R. (2012), Characteristics of HER2-positive breast cancer diagnosed following the introduction of universal HER2 testing. The Breast. 21(6), 724-729. [Abstract]
  • Balleine, R., Wilcken, N. (2012), High-Risk Estrogen-Receptor-Positive Breast Cancer: Identification and Implications for Therapy. Molecular Diagnosis & Therapy. 16(4), 235-240. [Abstract]
  • Khushi, M., Carpenter, J., Balleine, R., Clarke, C. (2012), Development of a data entry auditing protocol and quality assurance for a tissue bank database. Cell and Tissue Banking. 13(1), 9-13. [Abstract]
  • Khushi, M., Carpenter, J., Balleine, R., Clarke, C. (2012), Electronic biorepository application system: Web-based software to manage receipt, peer review, and approval of researcher applications. Biopreservation and Biobanking. 10(1), 37-44.


  • Haiman, C., Chen, G., Vachon, C., Canzian, F., Dunning, A., Millikan, R., Wang, X., Ademuyiwa, F., Ahmed, S., Ambrosone, C., Baglietto, L., Balleine, R., Bandera, E., Beckmann, M., Berg, C., Bernstein, L., Blomqvist, C., Blot, W., Brauch, H., Buring, J., Carey, L., Carpenter, J., Chang-Claude, J., Chanock, S., Chasman, D., Clarke, C., Cox, A., Cross, S., Deming, S., Diasio, R., Dimopoulos, A., Driver, W., Dünnebier, T., Durcan, L., Eccles, D., Edlund, C., Ekici, A., Fasching, P., Feigelson, H., Flesch-Janys, D., Fostira, F., Försti, A., Fountzilas, G., Gerty, S., Giles, G., Godwin, A., Goodfellow, P., Graham, N., Greco, D., Hamann, U., Hankinson, S., Hartmann, A., Hein, R., Heinz, J., Holbrook, A., Hoover, R., Hu, J., Hunter, D., Ingles, S., Irwanto, A., Ivanovich, J., John, E., Johnson, N., Jukkola-Vuorinen, A., Kaaks, R., Ko, Y., Kolonel, L., Konstantopoulou, I., Kosma, V., Kulkarni, S., Lambrechts, D., Lee, A., Le Marchand, L., Lesnick, T., Liu, J., Lindstrom, S., Mannermaa, A., Margolin, S., Martin, N., Miron, P., Montgomery, G., Nevanlinna, H., Nickels, S., Nyante, S., Olswold, C., Palmer, J., Pathak, H., Pectasides, D., Perou, C., Peto, J., Pharoah, P., Pooler, L., Press, M., Pylkäs, K., Rebbeck, T., Rodriguez-Gil, J., Rosenberg, L., Ross, E., Rüdiger, T., Silva, I., Sawyer, E., Schmidt, M., Schulz-Wendtland, R., Schumacher, F., Severi, G., Sheng, X., Signorello, L., Sinn, H., Stevens, K., Southey, M., Tapper, W., Tomlinson, I., Hogervorst, F., Wauters, E., Weaver, J., Wildiers, H., Winqvist, R., Berg, D., Wan, P., Xia, L., Yannoukakos, D., Zheng, W., Ziegler, R., Siddiq, A., Slager, S., Stram, D., Easton, D., Kraft, P., Henderson, B., Couch, F. (2011), A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nature Genetics. 43(12), 1210-1214. [Abstract]
  • Stevens, K., Vachon, C., Lee, A., Slager, S., Lesnick, T., Olswold, C., Fasching, P., Miron, P., Eccles, D., Carpenter, J., Godwin, A., Ambrosone, C., Winqvist, R., Brauch, H., Schmidt, M., Cox, A., Cross, S., Sawyer, E., Hartmann, A., Beckmann, M., Schulz-Wendtland, R., Ekici, A., Tapper, W., Gerty, S., Durcan, L., Graham, N., Hein, R., Nickels, S., Flesch-Janys, D., Heinz, J., Sinn, H., Konstantopoulou, I., Fostira, F., Pectasides, D., Dimopoulos, A., Fountzilas, G., Clarke, C., Balleine, R., Olson, J., Fredericksen, Z., Diasio, R., Pathak, H., Ross, E., Weaver, J., Rüdiger, T., Försti, A., Dünnebier, T., Ademuyiwa, F., Kulkarni, S., Pylkäs, K., Jukkola-Vuorinen, A., Ko, Y., Van Limbergen, E., Janssen, H., Peto, J., Fletcher, O., Giles, G., Baglietto, L., Verhoef, S., Tomlinson, I., Kosma, V., Beesley, J., Greco, D., Blomqvist, C., Irwanto, A., Liu, J., Blows, F., Dawson, S., Margolin, S., Mannermaa, A., Martin, N., Montgomery, G., Lambrechts, D., Dos Santos Silva, I., Severi, G., Hamann, U., Pharoah, P., Easton, D., Chang-Claude, J., Yannoukakos, D., Nevanlinna, H., Wang, X., Couch, F. (2011), Common Breast Cancer Susceptibility Loci Are Associated with Triple-Negative Breast Cancer. Cancer Research. 71(19), 6240-6249. [Abstract]
  • Houssami, N., Macaskill, P., Balleine, R., Bilous, M., Pegram, M. (2011), HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis. Breast Cancer Research and Treatment. 129(3), 659-674. [Abstract]
  • Emmanuel, C., Gava, N., Kennedy, C., Balleine, R., Sharma, R., Wain, G., Brand, A., Hogg, R., Etemadmoghadam, D., George, J., Birrer, M., Clarke, C., Chenevix-Trench, G., Bowtell, D., Harnett, P., Defazio, A. (2011), Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis. PLoS One. 6(3), e17617. [Abstract]


  • Balleine, R., Provan, P., Pupo, G., Pathmanathan, N., Cummings, M., Farshid, G., Salisbury, E., Bilous, A., Byth, K., Mann, G. (2010), Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case families. Genes, chromosomes & cancer. 49(12), 1082-94. [Abstract]
  • Pathmanathan, N., Albertini, A., Provan, P., Milliken, J., Salisbury, E., Bilous, A., Byth, K., Balleine, R. (2010), Diagnostic evaluation of papillary lesions of the breast on core biopsy. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 23(7), 1021-8. [Abstract]
  • Spurdle, A., Lakhani, S., Da Silva, L., Balleine, R., Goldgar, D. (2010), Bayes analysis provides evidence of pathogenicity for the BRCA1 c.135-1G>T (IVS3-1) and BRCA2 c.7977-1G>C (IVS17-1) variants displaying in vitro splicing results of equivocal clinical significance. Human Mutation. 31(2), E1141-E1145. [Abstract]
  • Pathmanathan, N., Salisbury, E., Provan, P., Bilous, A., Byth, K., Milliken, J., Clarke, C., Balleine, R. (2010), A class discovery and class prediction approach to histopathological classification of mammographic screen detected columnar cell lesions of the breast. Pathology. 42(1), 28-36. [Abstract]
  • Da Silva, L., Simpson, P., Smart, C., Cocciardi, S., Waddell, N., Lane, A., Morrison, B., Vargas, A., Healey, S., Beesley, J., Pakkiri, P., Parry, S., Kurniawan, N., Reid, L., Keith, P., Faria, P., Pereira, E., Skalova, A., Bilous, M., Balleine, R., Do, H., Dobrovic, A., Fox, S., Franco, M., Reynolds, B., Khanna, K., Cummings, M., Chenevix-Trench, G., Lakhani, S. (2010), HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer. Breast Cancer Research. 12(4), R46. [Abstract]


  • Graham, J., Mote, P., Salagame, U., Balleine, R., Huschtscha, L., Clarke, C. (2009), Hormone-Responsive Model of Primary Human Breast Epithelium. Journal of Mammary Gland Biology and Neoplasia. 14(4), 367-379. [Abstract]
  • Graham, J., Mote, P., Salagame, U., van Dijk, J., Balleine, R., Huschtscha, L., Reddel, R., Clarke, C. (2009), DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology. 150(7), 3318-3326. [Abstract]


  • Balleine, R., Webster, L., Davis, S., Salisbury, E., Palazzo, J., Schwartz, G., Cornfield, D., Walker, R., Byth, K., Clarke, C., Meltzer, P. (2008), Molecular Grading of Ductal Carcinoma In situ of the Breast. Clinical Cancer Research. 14(24), 8244-8252. [Abstract]
  • Scurr, L., Guminski, A., Chiew, Y., Balleine, R., Sharma, R., Lei, Y., Pryor, K., Wain, G., Brand, A., Byth, K., Kennedy, C., Rizos, H., Harnett, P., Defazio, A. (2008), Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer. Clinical Cancer Research. 14(21), 6924-6932. [Abstract]
  • Webster, L., Lee, S., Ringland, C., Morey, A., Hanby, A., Morgan, G., Byth, K., Mote, P., Provan, P., Ellis, I., Green, A., Lamoury, G., Ravdin, P., Clarke, C., Ward, R., Balleine, R., Hawkins, N. (2008), Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification. Clinical Cancer Research. 14(20), 6625-6633. [Abstract]
  • Balleine, R., Bilous, M., Morey, A. (2008), Painting by numbers: The power and peril of synoptic pathology reporting for cancer. Asia-Pacific Journal of Clinical Oncology. 4(2), 75-76.
  • Loughrey, M., Provan, P., Byth, K., Balleine, R., kConFab, I. (2008), Histopathological features of ''BRCAX'' familial breast cancers in the kConFab resource. Pathology. 40(4), 352-358. [Abstract]